top of page
Meeting

BUILDING SCALABLE PHARMACOVIGILANCE OPERATIONS

Pharmacovigilance Leadership, Safety Infrastructure & Inspection Readiness for Antibody Development

Meeting

THE CHALLENGE

As antibody programs advance through clinical development, pharmacovigilance becomes increasingly complex. Safety operations that may have been sufficient during early development often struggle to keep pace with larger studies, expanding vendor networks, increasing regulatory expectations, and growing organizational complexity.

 

Organizations frequently find themselves needing to implement new safety systems, transition between CROs, establish governance processes, negotiate safety agreements, or prepare for regulatory inspections without having experienced pharmacovigilance leadership already in place.

 

The result can be fragmented processes, inconsistent vendor oversight, compliance risk, and operational inefficiencies that place unnecessary pressure on development teams during critical stages of the program.


THE SOLUTION

SciLnq provides experienced pharmacovigilance leadership that helps antibody developers build practical, scalable safety operations designed to support today's development needs and tomorrow's milestones.

​

Rather than simply meeting regulatory requirements, our professionals help organizations establish the operational foundation required to confidently advance clinical programs while maintaining regulatory readiness.

​

From building pharmacovigilance functions from the ground up to optimizing mature global safety organizations, we work directly with sponsor teams to strengthen governance, streamline operations, improve vendor performance, and prepare programs for what comes next.

422293.jpg


CORE AREAS OF SUPPORT

Pharmacovigilance Infrastructure Development
Design and implement scalable pharmacovigilance organizations, governance
structures, and operating models that support clinical development and commercial programs.

 

Safety Vendor & CRO Oversight
Provide strategic oversight of CROs, safety vendors, and business partners while
establishing accountability, performance metrics, and collaborative operating models.

 

Safety Systems Strategy
Lead implementation, optimization, and transition of safety databases and operational
technologies to improve efficiency, compliance, and inspection readiness.

 

Inspection Readiness
Prepare organizations for FDA and global regulatory inspections through operational
assessments, process improvements, documentation reviews, and quality oversight.

 

Regulatory Safety Reporting
Support development and oversight of DSURs, PBRERs, safety narratives, signal
management activities, and global aggregate reporting strategies.

 

Safety Agreements
Negotiate and manage Safety Data Exchange Agreements (SDEAs),
Pharmacovigilance Agreements (PVAs), and partner responsibilities across complex
development programs.

 

SOP & Quality System Development
Develop practical, scalable SOPs, work instructions, governance processes, and quality
systems that support evolving program and organizational growth.

 

Cross-Functional Safety Leadership
Partner closely with Clinical Operations, Regulatory Affairs, Medical Affairs, Quality, and
Executive Leadership to align pharmacovigilance strategy with broader development
objectives.

OUR COMMITMENT TO SPONSORS

Your Program's Success is Our Priority.

​

SciLnq is built around a simple principle: our success is measured by the success of the sponsors and programs we support.

​

Our professionals bring experienced judgment, clear communication, and accountability to every engagement, working alongside sponsor teams with a shared commitment to the program and its objectives.

​

Whether strengthening safety operations, navigating a critical development milestone, or preparing for what comes next, our focus remains the same: provide the expertise, execution, and partnership needed to help your program succeed.

​

People Doing Handshakes.jpg
Group


HOW WE ENGAGE

Pharmacovigilance Leadership That Strengthens Safety Operations Across Every Stage of Development.

​

SciLnq integrates experienced pharmacovigilance professionals directly within sponsor organizations to provide strategic leadership, operational execution, and regulatory continuity where it is needed most. Whether supporting a growing safety function, leading a critical initiative, or providing fractional pharmacovigilance leadership, our professionals adapt to the needs and stage of your program.

​

Rather than functioning solely as external advisors, our professionals become an extension of your team, helping strengthen safety governance, improve vendor oversight, maintain inspection readiness, and build scalable pharmacovigilance operations that support programs as they advance.

​


WHY SCILNQ

Successful Pharmacovigilance Requires More Than Regulatory Compliance. It Requires Experienced Leadership That Can Build Scalable Safety Operations While Supporting the Evolving Needs of Antibody Development Programs.

​

SciLnq provides embedded pharmacovigilance expertise that helps sponsors strengthen safety infrastructure without the delay and overhead of traditional hiring. Our professionals integrate directly with sponsor teams to provide leadership, execution, and operational continuity across critical stages of clinical development.

​

Whether supporting a single clinical program, preparing for regulatory inspection, implementing new safety systems, or building a global pharmacovigilance function, SciLnq provides practical expertise that helps sponsors reduce operational risk while strengthening patient safety and regulatory confidence.

Meeting


READY TO STRENGTHEN YOUR PHARMACOVIGILANCE OPERATIONS? 

Whether you're building a pharmacovigilance function, preparing for regulatory inspections, implementing new safety systems, or scaling global safety operations, SciLnq provides experienced leadership that helps sponsors strengthen compliance, improve operational performance, protect patient safety, and keep development programs moving forward.

bottom of page